About Helsinn Healthcare

Welcome to Helsinn’s LinkedIn page.

This account shall only be used to share (*) news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional

Helsinn is a fully integrated, global biopharma company headquartered in Lugano, Switzerland. It is focused on improving the lives of cancer patients all over the world with a leading position in cancer supportive care and an innovative pipeline of cancer therapeutics.
Helsinn is a third-generation family-owned company, that since 1976 has been focused on improving the lives of patients, guided by core values of respect, integrity and quality. It operates a unique licensing business model with integrated drug development and manufacturing capabilities. Helsinn has a commercial presence in 190 countries either directly, with operating subsidiaries in the U.S. and China, or via its long-standing trusted partners. Helsinn also has a fully integrated supply chain and product development through its subsidiary in Ireland, Helsinn Birex Pharmaceuticals Ltd.

If you are interested in joining Helsinn or one of our affiliates, please visit helsinn.com. Applications should only be submitted via the appropriate country portal under “Working for Helsinn”. Any other sources of communications are unauthorized, and we discourage candidates from replying to suspect employment offers received through unofficial channels. If you are experiencing problems or have questions, please contact: Switzerland: [email protected], U.S.: [email protected], Ireland: [email protected]. [These emails are NOT an application channel: CVs and sensitive information sent inappropriately to the above emails will NOT be considered or processed, and will be DELETED]

website icon
Website
employees icon
Employees
industry icon
Industry
Pharmaceuticals
location icon
Location
Via Pian Scairolo 9, Lugano/Pazzallo, Ticino 6912, CH
description icon
Founded
1976
description icon
Keywords
Licensing Of Pharmaceuticals, Medical Devices And Nutritional Supplement Products, With Focus On Cancer Supportive Care To Benefit Both Patients With Cancer And Caregivers

Helsinn Healthcare Alternatives

Industry
Pharmaceuticals
Industry
pharmaceuticals
Industry
Pharmaceuticals
Industry
Pharmaceuticals
Industry
pharmaceuticals
Industry
pharmaceuticals

Frequently Asked Questions about Helsinn Healthcare

Who is the CEO of Helsinn Group?

Deirdre Hurley is the CEO of Helsinn Group. To contact Deirdre Hurley email at [email protected].

Who are the decision makers in Helsinn Group?

The decision makers in Helsinn Group are Amy Peterpaul, Daniele Balestreri, Deirdre Hurley, etc. Click to Find Helsinn Group decision makers emails.

What types of products does Helsinn specialize in?

Helsinn specializes in the licensing of pharmaceuticals, medical devices, and nutritional supplement products. The company focuses particularly on cancer supportive care, aiming to provide solutions that benefit both patients with cancer and their caregivers.

How does Helsinn support cancer patients and caregivers?

Helsinn supports cancer patients and caregivers by developing and providing innovative products that alleviate the side effects of cancer treatments. This includes medications that manage symptoms such as nausea and pain, as well as nutritional supplements that help improve the overall well-being of patients undergoing treatment.

What industries does Helsinn operate in?

Helsinn operates primarily within the healthcare industry, focusing on oncology and supportive care. The company collaborates with various stakeholders, including healthcare professionals, regulatory bodies, and other pharmaceutical companies, to ensure that their products meet the needs of patients and caregivers.

Can healthcare providers partner with Helsinn for product distribution?

Yes, Helsinn is open to partnerships with healthcare providers and other organizations interested in distributing their products. The company values collaboration and seeks to expand access to their innovative solutions in cancer supportive care through strategic partnerships.

What is Helsinn's approach to research and development?

Helsinn is committed to research and development, focusing on creating effective solutions for cancer supportive care. The company invests in clinical trials and collaborates with research institutions to ensure that their products are evidence-based and meet the highest standards of safety and efficacy.

How can I stay updated on Helsinn's latest news and developments?

To stay updated on Helsinn's latest news and developments, you can follow their official LinkedIn page. The company regularly shares updates regarding new product launches, research findings, and other relevant information related to their mission in cancer supportive care.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more